pubmed-article:10535608 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10535608 | lifeskim:mentions | umls-concept:C0015674 | lld:lifeskim |
pubmed-article:10535608 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
pubmed-article:10535608 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:10535608 | pubmed:dateCreated | 1999-11-18 | lld:pubmed |
pubmed-article:10535608 | pubmed:abstractText | Based upon the clinical presentation of chronic fatigue syndrome (CFS), we hypothesized that proinflammatory cytokines may play a role in the pathogenesis of the disease. We therefore undertook a retrospective cross-sectional study to examine the role of TNF-alpha in patients with CFS. Our results suggest a significant increase serum TNF-alpha in patients with CFS (P<0.0001) compared to non-CFS controls. This study supports the further examination of the role of proinflammatory mediators in CFS. Furthermore, the clinical testing of TNF-alpha blockers and other antiinflammatory agents for the treatment of this disease is warranted. | lld:pubmed |
pubmed-article:10535608 | pubmed:language | eng | lld:pubmed |
pubmed-article:10535608 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10535608 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10535608 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10535608 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10535608 | pubmed:month | Sep | lld:pubmed |
pubmed-article:10535608 | pubmed:issn | 0271-9142 | lld:pubmed |
pubmed-article:10535608 | pubmed:author | pubmed-author:VojdaniAA | lld:pubmed |
pubmed-article:10535608 | pubmed:author | pubmed-author:MossR BRB | lld:pubmed |
pubmed-article:10535608 | pubmed:author | pubmed-author:MercandettiAA | lld:pubmed |
pubmed-article:10535608 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10535608 | pubmed:volume | 19 | lld:pubmed |
pubmed-article:10535608 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10535608 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10535608 | pubmed:pagination | 314-6 | lld:pubmed |
pubmed-article:10535608 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:10535608 | pubmed:meshHeading | pubmed-meshheading:10535608... | lld:pubmed |
pubmed-article:10535608 | pubmed:meshHeading | pubmed-meshheading:10535608... | lld:pubmed |
pubmed-article:10535608 | pubmed:meshHeading | pubmed-meshheading:10535608... | lld:pubmed |
pubmed-article:10535608 | pubmed:meshHeading | pubmed-meshheading:10535608... | lld:pubmed |
pubmed-article:10535608 | pubmed:meshHeading | pubmed-meshheading:10535608... | lld:pubmed |
pubmed-article:10535608 | pubmed:meshHeading | pubmed-meshheading:10535608... | lld:pubmed |
pubmed-article:10535608 | pubmed:meshHeading | pubmed-meshheading:10535608... | lld:pubmed |
pubmed-article:10535608 | pubmed:meshHeading | pubmed-meshheading:10535608... | lld:pubmed |
pubmed-article:10535608 | pubmed:meshHeading | pubmed-meshheading:10535608... | lld:pubmed |
pubmed-article:10535608 | pubmed:meshHeading | pubmed-meshheading:10535608... | lld:pubmed |
pubmed-article:10535608 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10535608 | pubmed:articleTitle | TNF-alpha and chronic fatigue syndrome. | lld:pubmed |
pubmed-article:10535608 | pubmed:affiliation | The Immune Response Corporation, Carlsbad, California 92008, USA. shotdoc@imnr.com | lld:pubmed |
pubmed-article:10535608 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10535608 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10535608 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10535608 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10535608 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10535608 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10535608 | lld:pubmed |